Blog / Archives
Biotech Momentum Picks Up: CRSP MRK XBI…Updates 10/29,31.
Update 10/30 1:45 pm EDT Markets weak on China deal, PMI data Sold CRSP at $50.with 25% gain in 2 weeks; will get back in on weakness. XBI off 0.89%, IBB down 0.85%, NAZ off 0.44%. BMY up 1.5% near...
Biotech Snapshot on a Lackluster Day-ALXN, BMRN…Update-10/25
Update-1 10/25 at close...A Good Day on Low Volume-NASDAQ up 0.7%, S&P is up 20.56% YTD! Large caps mixed with IBB down a tad 0.29%;leaders are BIIB,BMY,RHHBY NASDAQ-100 at record high; QQQ up...
Bullish Trends in Biotech Today-Rebalance Portfolio with Healthcare…Update-1 Biogen
Update-1 10/22. Some follow through in biotech rally but sold off mirroring the NASDAQ about 2p,Maybe BREXIT related but we'll see later this week after many earnings reports. Large caps have been...
Surprisingly Strong Earnings Spark Healthcare Stocks : Time to Rebalance Your Portfolio…Update-1
Update-1 Large caps were mixed but our top picks are doing well: ABBV,BMY,MRK,RHHBY. But bad news from JNJ and BA may have curbed buyer's sentiment. United Health (UNH) off Mondays lows of $220 to...
Biotech Stocks Mired in Uncertainty: China Deal, Drug Pricing Politics and Earnings Outlook…Update-2 Rally Day
Update-2 10/13...Biotech IPOs Remain Weak-Recent rally was weak for small cap biotechs Vir Biotechnology (VIR): A clinical stage immunology and infectious disease Company focused on new therapies...
Large Cap Biopharma in Focus: Core Positions…Risk OFF…Updates
10/09/19 Better tape today but a lot of random churning and tactical trading, biopharma under siege? NASDAQ up 1.17%. Talk about mini-deal with China. Large cap leaders with IBB flat: REGN MRK BMY....
Biotech Snapshot: Bears Are Digging In…Update-2… Upside Reversal
Update-2 10/4 Broad Rally day: all major averages up 1.4%, NAZ at 7982. Risk back on. But biotech lags major indices IBB up 0.75%, XBI up 0.21% to $76.82. Better trade for biotech has been large...
Biopharma Stocks Mired in Macro-Risk Off…Update-2…”Future of Biotech” from Barrons’s
With biotech in a funk this timely article from Barron's should help. Barron's to the Rescue: Future of Biotech, article offers picks from a new Roundtable (above link may not open because requires...
What Did I Miss While I was on Vacation in September: Biotech Wrap-Up in a Sideways Market…Update-1
Update-1 A bit of a sell-off on end of week option expirations and cancellation of China visit to farm Bureau in MT. NAZ down 0.8%, S&P down 0.5%. Less reaction to China news now? Can biotech...